- Home
- Companies
- north america
- heart transplant
Show results for
Refine by
Heart Transplant Suppliers In North America
14 companies found
based inGöteborg, SWEDEN
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. Getinge Infection Control (GETINGE) is one out of three business areas within Getinge AB, a ...
based inSouth San Francisco, CALIFORNIA (USA)
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions. Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant ...
AlloMap is an innovative diagnostic test that helps identify patients with stable allograft function who have a low probability of moderate to severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical ...
based in, ARIZONA (USA)
To manage patients with advanced heart failure, every clinician will have the technology awareness and outcome data necessary to confidently consider the TAH as a therapeutic option. At SynCardia Systems, LLC, we have a very special mission: to give ...
The SynCardia 70cc temporary Total Artificial Heart (TAH) is the world’s first and only commercially approved total heart replacement. With more than 1,700 implants worldwide, the 70cc TAH accounts for more than 600 patient-years of ...
based inSalt Lake City, UTAH (USA)
Second Heart Assist, Inc. has developed both a catheter-based circulatory assist pump and a wireless power chronic implant aortic stent pump to aid patients with heart failure and reverse cardio-renal dysfunction. The company completed the first ...
Second Heart Assist objectives are to improve the quality of life by reducing the heart’s work-load and improve perfusion. The enhancement of renal function reduces risks associated with toxic contrasts used in percutaneous catheterization ...
based inMiami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
We are testing Lomecel-B as a potential combinatorial therapy candidate to surgical intervention for HLHS. The scientific goal underlying this study builds on surgical advances of the past thirty years, and is intended to address remaining obstacles ...
based inSanta Clara, CALIFORNIA (USA)
Ancora Heart is dedicated to providing new treatment options for patients suffering from heart failure. Our team has a deep appreciation for the challenges faced by the estimated 26 million patients across the globe who are living with this chronic, ...
Heart failure, sometimes called congestive heart failure or CHF, is a condition in which your heart slowly weakens and loses its ability to pump enough oxygen-rich blood to the body. It is a chronic, progressive disease, which means there is no ...
based inNew York, NEW YORK (USA)
Jarvik Heart, Inc. is a private company that develops miniaturized heart assist devices for the treatment of severe heart failure. The company, formed in 1988, is located in Manhattan, where it conducts development and manufacturing activities. ...
The Jarvik 2000® is designed to provide reliable support to the ailing heart for a decade or longer. Accelerated tests of the pump’s bearings show that there is so little wear that the bearings will last decades, so many ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Aviptadil is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects. Aviptadil induces pulmonary vasodilation and inhibits vascular SMCs proliferation, platelet aggregation. Aviptadil can be used for the research of ...
based inBuffalo Grove, ILLINOIS (USA)
BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant – lifesaving technology that gives patients the gift of time. With ...
based inSan Ramon, CALIFORNIA (USA)
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of ...
based inMonmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...
he CytoSorb therapy* is based on an extracorporeal blood purification procedure that was shown to effectively reduce excessive levels of inflammatory mediators (see “The Adsorber”). This is intended to alleviate the excess systemic ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
based inHouston, TEXAS (USA)
BiVACOR is a privately held company founded in 2008. Our staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, we have established a ...
The BiVACOR is a total artificial heart designed to take over the complete function of a patient’s failing heart. Implantation of a TAH is a treatment option for patients with end-stage HF who need support ...
based inEdgewater, NEW JERSEY (USA)
Menssana Research is the leading developer of advanced new breath tests for detection of disease. Early detection of diseases can often bring huge benefits: some cancers can be completely eradicated if they are detected early and treated promptly. ...
The HeartsbreathTM test is a non-invasive breath test for breath biomarkers that predict the probability of grade 3 rejection in heart transplant recipients who received their transplants in the ...